1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Body Weight in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (15.79) | 18.7374 |
| 1990's | 11 (57.89) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 1 (5.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antonopoulou, S; Arampatzi-Menenakou, K; Fragopoulou, E; Kalathara, K; Melachroinou, S; Xanthopoulou, MN; Yannakoulia, M | 1 |
| Akamine, E; Carvalho, MH; Fortes, ZB; Nigro, D; Passaglia, RC; Toledo, DP | 1 |
| Antonopoulou, S; Demopoulos, CA; Fragopoulou, E; Karantonis, HC; Phenekos, C; Rementzis, J | 1 |
| Antonopoulou, S; Demopoulos, CA; Iliopoulos, DG; Karantonis, HC; Perrea, DN; Theocharis, SE; Tsantila, N | 1 |
| Bremer, C; Lang, H; Oldhafer, KJ; Pichlmayr, R; Schüttler, W; Spiegel, HU | 1 |
| Brecht, HM; Haberstroh, U; Mihatsch, MJ; Oberle, G; Stahl, RA; Thaiss, F | 1 |
| Ibe, BO; Johnson, C; Kurantsin-Mills, J; Oh, SO; Raj, JU | 1 |
| Akiyama, H; Goda, Y; Okunuki, H; Sakushima, J; Sawada, JI; Teshima, R; Toyoda, M | 1 |
| Ben-Bassat, M; Blank, M; Krause, I; Shoenfeld, Y | 1 |
| Ichimaru, T; Tai, HH | 1 |
| Mustoe, TA; Porras-Reyes, BH | 1 |
| Abiru, T; Kamata, K; Kasuya, Y | 1 |
| Barros, EJ; Boim, MA; Braquet, P; dos Santos, OF; Pirotzky, E; Schor, N | 1 |
| Baum, TD; Feldman, HS; Fink, MP; Heard, SO; Latka, CA | 1 |
| Braquet, P; Guilmard, C; Ivanow, F; Pirotzky, E; Principe, P; Sidoti, C | 1 |
| Hyers, TM; Lagunoff, D; Ohar, JA; Pyle, JA; Waller, KS; Webster, RO | 1 |
| Mathias, M; Morganroth, ML; Pickett, WC; Reeves, JT; Voelkel, NF; Worthen, S | 1 |
| Beilin, LJ; Codde, J; Croft, KD; Vandongen, R | 1 |
| Anderson, RC; Arroyave, JL; Gonzalez-Crussi, F; Houlihan, WJ; Hsueh, W; Lee, ML | 1 |
2 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Body Weight
| Article | Year |
|---|---|
Wine consumption reduced postprandial platelet sensitivity against platelet activating factor in healthy men.
Topics: Adult; Atherosclerosis; Biomarkers; Blood Platelets; Body Mass Index; Body Weight; Cholesterol; Cross-Over Studies; Humans; Male; Plasminogen Activator Inhibitor 1; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Postprandial Period; Triglycerides; Wine | 2017 |
Effect of fast-food Mediterranean-type diet on type 2 diabetics and healthy human subjects' platelet aggregation.
Topics: Adenosine Diphosphate; Animals; Arachidonic Acid; Blood Platelets; Body Weight; Diabetes Mellitus, Type 2; Diet; Diet, Mediterranean; Energy Intake; Food Analysis; Humans; Lipids; Middle Aged; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Reference Values; Restaurants | 2006 |
17 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Body Weight
| Article | Year |
|---|---|
Microvascular reactivity in experimental diabetes: responses of male and female rats.
Topics: Acetylcholine; Angiotensin II; Animals; Body Weight; Bradykinin; Diabetes Mellitus, Experimental; Estrous Cycle; Female; Histamine; Hypoglycemic Agents; Insulin; Male; Microcirculation; Nitroprusside; Norepinephrine; Organ Size; Platelet Activating Factor; Rats; Rats, Wistar; Sex Characteristics; Uterus; Vasoconstrictor Agents; Vasodilator Agents | 2003 |
Antithrombotic and antiatherosclerotic properties of olive oil and olive pomace polar extracts in rabbits.
Topics: Animals; Atherosclerosis; Blood Platelets; Body Weight; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Chromatography, Gas; Chromatography, High Pressure Liquid; Diet, Atherogenic; Eating; Fatty Acids; Fibrinolytic Agents; Glycolipids; Male; Olea; Olive Oil; Plant Extracts; Plant Oils; Platelet Activating Factor; Platelet Aggregation; Protein Binding; Rabbits | 2007 |
Beneficial effect of the platelet-activating factor antagonist WEB 2170 on reperfusion injury after orthotopic liver transplantation.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Azepines; Bilirubin; Body Weight; Graft Survival; Liver; Liver Function Tests; Liver Transplantation; Platelet Activating Factor; Platelet Aggregation Inhibitors; Reperfusion Injury; Swine; Time Factors; Triazoles | 1995 |
Platelet-activating factor receptor antagonist improves renal function and glomerular lesions in renal ablation.
Topics: Albuminuria; Animals; Azepines; Blood Pressure; Body Weight; Eicosanoids; Inulin; Kidney; Kidney Glomerulus; Male; Nephrectomy; Organ Size; p-Aminohippuric Acid; Platelet Activating Factor; Rats; Rats, Wistar; Triazoles | 1994 |
Platelet-activating factor in plasma of patients with sickle cell disease in steady state.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adolescent; Adult; Aging; Anemia, Sickle Cell; Blood Platelets; Body Weight; Female; Hemoglobins; Humans; Male; Phospholipases A; Platelet Activating Factor; Platelet Count | 1997 |
Induction of active systemic anaphylaxis by oral sensitization with ovalbumin in mast-cell-deficient mice.
Topics: Administration, Oral; Anaphylaxis; Animals; Body Weight; Disease Models, Animal; Female; Fever; Food Hypersensitivity; Histamine; Injections, Intraperitoneal; Interferon-gamma; Interleukin-4; Mast Cells; Mice; Mice, Mutant Strains; Organ Size; Ovalbumin; Platelet Activating Factor; Th2 Cells | 2000 |
Induction of experimental anti-phospholipid syndrome associated with SLE following immunization with human monoclonal pathogenic anti-DNA idiotype.
Topics: Animals; Antibodies, Anticardiolipin; Antibodies, Antinuclear; Antiphospholipid Syndrome; Body Weight; Cross Reactions; Disease Models, Animal; Female; Fetal Resorption; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Organ Size; Phospholipids; Placenta; Platelet Activating Factor; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Vaccination | 1992 |
Alteration of platelet activating factor (PAF) metabolism in rat pulmonary alveolar macrophages and plasma by cigarette smoking.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acetyltransferases; Animals; Blood Platelets; Body Weight; Bronchoalveolar Lavage Fluid; Calcimycin; Macrophages, Alveolar; Male; Phospholipases A; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Tobacco Smoke Pollution | 1992 |
Platelet-activating factor: improvement in wound healing by a chemotactic factor.
Topics: Animals; Blood Pressure; Body Weight; Female; Furans; Heart Rate; Immunoenzyme Techniques; Male; Platelet Activating Factor; Rats; Rats, Inbred Strains; Sex Characteristics; Time Factors; Wound Healing; Wounds and Injuries | 1992 |
Attenuation of depressor response induced by platelet activating factor and acetylcholine in streptozotocin-induced diabetic rats.
Topics: Acetylcholine; Anesthesia; Animals; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Experimental; Male; Mesenteric Arteries; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroprusside; Perfusion; Platelet Activating Factor; Rats; Rats, Inbred Strains; Vasodilation | 1991 |
Effect of platelet-activating factor antagonist BN 52063 on the nephrotoxicity of cisplatin.
Topics: Animals; Blood Pressure; Blood Proteins; Body Weight; Cisplatin; Diuresis; Glomerular Filtration Rate; Kidney; Lactones; Male; Plant Extracts; Platelet Activating Factor; Rats; Rats, Inbred Strains; Reference Values; Renal Circulation; Vascular Resistance | 1991 |
Endotoxin-induced myocardial depression in rats: effect of ibuprofen and SDZ 64-688, a platelet activating factor receptor antagonist.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Body Weight; Depression, Chemical; Endotoxins; Escherichia coli; Heart Rate; Ibuprofen; In Vitro Techniques; Lipopolysaccharides; Male; Myocardial Contraction; Platelet Activating Factor; Rats; Rats, Inbred Strains | 1990 |
Platelet-activating factor antagonist, BN-52021 protects against cis-diamminedichloroplatinum nephrotoxicity in the rat.
Topics: Acute Kidney Injury; Animals; Blood Urea Nitrogen; Body Weight; Cisplatin; Creatinine; Diterpenes; Ginkgolides; Glomerular Filtration Rate; Lactones; Male; Platelet Activating Factor; Rats; Rats, Inbred Strains; Renal Circulation; Tumor Cells, Cultured | 1990 |
A rabbit model of pulmonary hypertension induced by the synthetic platelet-activating factor acetylglyceryl ether phosphorylcholine.
Topics: Animals; Blood Cell Count; Body Weight; Bronchi; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Extravascular Lung Water; Heart Ventricles; Hemodynamics; Hypertension, Pulmonary; Platelet Activating Factor; Platelet Aggregation; Pulmonary Alveoli; Pulmonary Artery; Rabbits | 1990 |
Decreased pulmonary vascular responsiveness in rats raised on an essential fatty acid deficient diet.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Body Weight; Dietary Fats; Fatty Acids, Unsaturated; In Vitro Techniques; Lung; Male; Platelet Activating Factor; Rats; Rats, Inbred Strains; SRS-A; Vasoconstriction | 1987 |
The effect of dietary fish oil and long-term salt loading on blood pressure and eicosanoid metabolism in spontaneously hypertensive rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Pressure; Body Weight; Chromatography, Gas; Diet; Eicosanoids; Fatty Acids, Nonesterified; Fish Oils; Hypertension; Male; Platelet Activating Factor; Potassium; Rats; Rats, Inbred SHR; Sodium; Thromboxane B2; Urodynamics | 1988 |
Platelet activating factor-induced ischemic bowel necrosis: the effect of PAF antagonists.
Topics: Animals; Body Weight; Hematocrit; Intestine, Small; Ischemia; Lipopolysaccharides; Male; Necrosis; Platelet Activating Factor; Rats; Rats, Inbred Strains; Splanchnic Circulation; Thiazoles | 1986 |